MARKET

NBY

NBY

NOVABAY PHARMA
AMEX

Real-time Quotes | Nasdaq Last Sale

0.5251
+0.0169
+3.32%
Closed 16:00 02/18 EST
OPEN
0.5003
PREV CLOSE
0.5082
HIGH
0.5350
LOW
0.5003
VOLUME
94.90K
TURNOVER
--
52 WEEK HIGH
4.040
52 WEEK LOW
0.2290
MARKET CAP
14.65M
P/E (TTM)
-1.1272
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of NBY and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

NBY News

  • NovaBay Pharmaceuticals Launches NovaWipes Eyelid Wipes on Amazon.com
  • Business Wire.12/02/2019 11:50
  • Mid-Afternoon Market Update: Qudian Falls Following Downbeat Q3 Earnings; NovaBay Pharmaceuticals Shares Jump
  • Benzinga.11/18/2019 19:14
  • Mid-Day Market Update: Crude Oil Down 1.9%; Karuna Therapeutics Shares Spike Higher
  • Benzinga.11/18/2019 17:25
  • NovaBay launches NovaSight daily vitamin on Amazon.com; shares up 21% premarket
  • seekingalpha.11/18/2019 17:22

More

Industry

Biotechnology & Medical Research
+0.77%
Pharmaceuticals & Medical Research
-0.10%

Hot Stocks

Name
Price
%Change

About NBY

NovaBay Pharmaceuticals, Inc., formerly NovaCal Pharmaceuticals, Inc., is a biopharmaceutical company, which develops products for the eye care market. The Company focuses on commercializing prescription Avenova for managing hygiene of the eyelids and lashes in the United States. Avenova is an eye care product formulated with a form of hypochlorous acid called Neutrox. Its Avenova with Neutrox removes debris from the skin on the eyelids and lashes without burning or stinging. It develops additional products containing Neutrox, including its NeutroPhase Skin and Wound Cleanser for wound care and CelleRx for the dermatology market. Its Aganocide compounds, led by auriclosene (NVC-422), are synthetic molecules with activity against bacteria, viruses and fungi. The Company's dermatology product includes CelleRx, a cleansing solution for post laser resurfacing, chemical peels and other cosmetic surgery procedures. Its wound care business includes the business of NeutroPhase product.
More

Webull offers NovaBay Pharmaceuticals, Inc. (NBY) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.